Middle East News Center: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Center.

Press releases published on September 2, 2026

Sep. 2, 2026

RenovoRx to Present at H.C. Wainwright 28th Annual Global Investment Conference, September 14th-16th

Indeterminate GlobeNewswire

Sep. 2, 2026

One of Israel’s 3 Largest Defense Companies Begins Immediate Deployment of QTREX Quantum’s AME Technology

Indeterminate GlobeNewswire

Sep. 2, 2026

SELLAS Life Sciences to Present Preclinical Data on SLS009 in Pancreatic Ductal Adenocarcinoma at the 2026 AACR Conference on Pancreatic Cancer

Indeterminate GlobeNewswire

Sep. 2, 2026

Symbiotic Appoints Former Société Générale Asset Management APAC CEO Mahendran Nathan as Global Head of Onchain Solutions

Indeterminate GlobeNewswire

Sep. 2, 2026

Maris Tech Announces a 194% Increase in Company Revenues for the First Half 2026, Totaling Approximately $2.1 Million

Indeterminate GlobeNewswire

Sep. 2, 2026

R3 Life Wellness Brings Mindful Movement and Longevity Together at ANAPANA SATI

Indeterminate EIN Presswire

Sep. 2, 2026

GYMNATION TURNS OUT THE LIGHTS WITH 'DANS LE NOIR: CLASS IN THE DARK'

Indeterminate EIN Presswire

Sep. 2, 2026

ProQR to Participate in Upcoming Investor Conferences in September 2026

Indeterminate GlobeNewswire

Sep. 2, 2026

Seismic Therapeutic to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Aligos Therapeutics to Present at the Cantor Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 2, 2026

ALX Oncology to Present at Upcoming Investor Conferences in September

Indeterminate GlobeNewswire

Sep. 2, 2026

Milestone Pharmaceuticals to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

UroGen Pharma to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

BioAge Labs to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

GoldHaven Closes First Tranche of Flow-Through Financing and Increases Offering Up to $3.0 Million

Indeterminate GlobeNewswire

Sep. 2, 2026

Polyrizon Completes All Five U.S. Site Contracts for NASARIX™ First-in-Human Allergy Study

Indeterminate GlobeNewswire

Sep. 2, 2026

New U.S. Patent Allowance Strengthens Protection for CAPTN-3 Modular Platform for Next-Generation Multispecific Antibodies

Indeterminate GlobeNewswire

Sep. 2, 2026

BridgeBio to Present New Data on the Impact of Oral Infigratinib on Medical Complications in Achondroplasia at the Annual ESPE Meeting 2026

Indeterminate GlobeNewswire

Sep. 2, 2026

انطلاق الدورة الثالثة من معرض الاخشاب ضمن ملتقي الاخشاب الدولي في الرياض بحضور صناعي وتجاري دولي

Indeterminate GlobeNewswire

Sep. 2, 2026

Third Edition of Global WoodShow Part of Saudi Wood Forum Inaugurates in Riyadh with Significant International Participation

Indeterminate GlobeNewswire